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Schizophrenia is a complex disorder about which much is still unknown. Potential
treatments, such as transcranial magnetic stimulation (TMS), have not been exploited, in
part because of the variability in behavioral response. This can be overcome with the use
of response biomarkers. It has been however shown that repetitive transcranial magnetic
stimulation (rTMS) can the relieve positive and negative symptoms of schizophrenia,
particularly auditory verbal hallucinations (AVH). This exploratory work aims to establish
a quantitative methodological tool, based on high-density electroencephalogram
(HD-EEG) data analysis, to assess the effect of rTMS on patients with schizophrenia and
AVH. Ten schizophrenia patients with drug-resistant AVH were divided into two groups:
the treatment group (TG) received 1 Hz rTMS treatment during 10 daily sessions (900
pulses/session) over the left T3-P3 International 10-20 location. The control group (CG)
received rTMS treatment over the Cz (vertex) EEG location. We used the P300 oddball
auditory paradigm, known for its reduced amplitude in schizophrenia with AVH, and
recorded high-density electroencephalography (HD-EEG, 256 channels), twice for each
patient: pre-rTMS and 1 week post-rTMS treatment. The use of HD-EEG enabled the
analysis of the data in the time domain, but also in the frequency and source-space
connectivity domains. The HD-EEG data were linked with the clinical outcome derived
from the auditory hallucinations subscale (AHS) of the Psychotic Symptom Rating Scale
(PSYRATS), the Quality of Life Scale (QoLS), and the Depression, Anxiety and Stress
Scale (DASS). The general results show a variability between subjects, independent of
the group they belong to. The time domain showed a higher N1-P3 amplitude post-rTMS,
the frequency domain a higher power spectral density (PSD) in the alpha and beta bands,
and the connectivity analysis revealed a higher brain network integration (quantified using
the participation coefficient) in the beta band. Despite the small number of subjects and
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the high variability of the results, this work shows a robust data analysis and an interplay
between morphology, spectral, and connectivity data. The identification of a trend post-
rTMS for each domain in our results is a first step toward the definition of quantitative
neurophysiological parameters to assess rTMS treatment.
Keywords: high-density EEG, TMS (repetitive transcranial magnetic stimulation), P300, schizophrenia, spectral
analysis, temporal analysis, brain connectivity
1. INTRODUCTION
Hallucinations are sensory perceptions occurring in the absence
of an external stimulus. Auditory verbal hallucinations (AVH) are
positive psychotic symptoms of schizophrenia and a diagnostic
feature in the pathology, occurring in an estimated 60–70%
of people with this disorder. An increased interaction among
the auditory-language and striatal brain regions occurs while
patients hallucinate (Ćurčić Blake et al., 2017). Patients with
AVH present evidence of structural brain alterations associated
with these perceptions, such as reduced gray matter volume in
the superior temporal gyrus (Kasai et al., 2003), including the
primary auditory cortex, and abnormal connectivity among the
temporal, prefrontal, and anterior cingulate regions (Homan,
2013; Ćurčić Blake et al., 2017). Among the empirically supported
theories of the origin of AVH, are a misinterpretation of inner
speech (Frith and Done, 1988) and aberrant activation of the
auditory cortex (Dierks et al., 1999). Almost one-third of patients
with positive psychotic schizophrenia present treatment resistant
symptoms (Howes et al., 2009) and there is a compelling need for
novel treatments.
Transcranial magnetic stimulation (TMS) is a non-invasive
method used over the past 25 years in the treatment of
neurobehavioral disorders (Stanford et al., 2008). It uses an
alternating magnetic field to induce an electrical current in the
brain, depolarizing neurons and generating action potentials.
Wassermann et al. (1996) and Chen et al. (1997) reported that
1 Hz repetitive TMS (rTMS) reduces the excitability of cortical
neurons in healthy individuals. Based on these effects, Hoffman
et al. (1999) hypothesized that 1 Hz rTMS delivered to the left
temporoparietal cortex reduced activity in receptive language
areas associated with AVH in patients with schizophrenia.
Neuroimaging studies of AVH showed an increased activation in
the absence of an external stimulus in the left primary auditory
cortex of subjects with this symptom (Kompus et al., 2011).
Our goal was to establish a methodological tool to
quantitatively assess the cognitive processes of people suffering
with AVH. We aimed to develop an hypothesis that can
validate psychometric results with event related potential (ERP)
morphology (time domain), power spectral density (frequency
Abbreviations: AHS, Auditory Hallucinations Subscale; AVH, Auditory Verbal
Hallucinations; CG, Control Group; DASS, Depression Anxiety Stress Scale;
ERP, Event-related Potential; HD EEG, High Density Electroencephalogram;
PC, Participation coefficient; PSD, Power Spectral Density; PSYRATS, Psychotic
SymptomRating Scales; QoLS, Quality of Life Scale; rTMS, Repetitive Transcranial
Magnetic Stimulation; TG, Treatment Group; TMS, Transcranial Magnetic
Stimulation.
domain), and brain connectivity in patients undergoing 10
sessions of low-frequency rTMS.
To date, the mechanism of the effect of rTMS on AVH has
only been inferred from the hypothesis of left temporoparietal
cortex dysfunction and the behavioral response is variable from
patient to patient. Dozens of studies have used inhibitory low
frequency rTMS over the T3-P3 EEG location as a treatment
for pharmaco-resistant AVH with the effects measured mainly
with psychometric scales (Lefaucheur et al., 2014; Slotema et al.,
2014). Physiological measures linked to specific brain areas and
biomarkers of target engagement and response are needed to
optimize treatment. Indeed, response biomarkers are essential
as predictors of treatment where behavioral outcomes can be
variable. They may also be very useful for rTMS treatments,
where multiple parameters, including frequency, train length,
intensity, duration, and treatment schedule can all influence
effectiveness and should be optimized before full-scale clinical
trials are attempted. Past studies indicate a relation between
different frequency bands and cognitive processes (Klimesch
et al., 1998). The power spectral density (PSD) changes observed
in response to attentional demands can be of interest to monitor
patients with schizophrenia behavior. Electroencephalographic
(EEG)measures, including spectral density and evoked potentials
(Barr et al., 2011), have been used asmeasures of the physiological
response to TMS treatment. For instance, it has been observed
that rTMS to the dorsolateral prefrontal area increased the P300
response in patients with schizophrenia, but not healthy controls
(Lin et al., 2018).
The P300 first described by Sutton et al. (1965), mostly studied
as a parameter of voluntary attention (Mazaheri and Picton,
2005), is the leading Event Related Potential (ERP) correlate of
target discrimination (Mazaheri and Picton, 2005) and it has
been largely employed to characterize schizophrenia (Jeon and
Polich, 2003). Previous studies have found that patients with
auditory hallucinations exhibit reduced P300 amplitudes (Jeon
and Polich, 2003; Bramon et al., 2004; Fisher et al., 2014). Many
works based on P300 also analyzed N100, the negative deflection
that occurs approximately 100 ms after the auditory stimulus,
noting a relation with working memory (Lijffijt et al., 2009).
The mean amplitudes of the auditory N100 and P300 responses
are decreased in patients with schizophrenia in comparison to
healthy participants (Ogura et al., 1991; Ford et al., 2001; Earls
et al., 2016).
Here, we compared alterations in the P300 response after
left temporal and vertex [used as a control in previous
studies with schizophrenia and AVH (Nyffeler et al., 2006;
Nowak et al., 2008; Loo et al., 2010)] TMS in patients with
schizophrenia using three different approaches : time, frequency,
Frontiers in Neuroscience | www.frontiersin.org 2 November 2020 | Volume 14 | Article 575538
Aubonnet et al. HD-EEG P300 rTMS Schizophrenia
and source-space connectivity. Patients also underwent a battery
of neurobehavioral and tests before and after treatment.
We remained descriptive in our analysis before and after
treatment, at group and single levels.
2. MATERIALS AND METHODS
2.1. Participants
The patients were recruited from the psychiatric wards and
outpatient clinics of the National Hospital of Iceland. They
were diagnosed with schizophrenia, following the ICD-10
(International Classification of Diseases, Tenth Revision, Clinical
Modification) schizophrenia classification (F20). Only those still
experiencing persistent AVH after finishing at least two 6–8
week drug treatments were selected. Patients were excluded if
they had history of seizures, were using cannabis or drinking
more than three units of alcohol daily, were using any other
illegal drugs within 1 month prior to the beginning of the study,
or showing TMS contraindications during the pre-treatment
interview (Rossi et al., 2011). Permission from the Health
Research Ethics Committee at the University Hospital of Iceland
was obtained (approval no. 21.2018). Ten patients (7 men and
3 women, mean age = 32, SD = 6.41) were selected for the
study. All of them were taking medications. Table 1 sums up
the patient information. The patients were randomly assigned
into two groups. Five patients (four men and one woman, mean
age 35.2, SD = 5.12,range 30–48) were included in the active
treatment group (TG). They received ten daily sessions of 15 min
1 Hz frequency rTMS (900 pulses/session) at 100% of abductor
pollicis brevis resting motor threshold (RMT) applied at T3-P3
location. Five patients (three men and two women, mean age
29.6, SD = 3.92, range 26–39) were included in the control group
(CG) and received rTMS at 100% RMT to the vertex of CG
10-20 location. The EEG and psychometric data were acquired
twice in each patient group; before the rTMS treatment (pre-
treatment) and within 1 week after completing ten sessions of
rTMS treatment (post-treatment). This produced 20 datasets: five
pre-TMS TG, five post-TMS TG, five pre-TMS CG, and five post-
TMS CG. Figure 1 shows the experimental set-up and workflow
designed for this study. Figure 2 shows the pre-processing and
data analysis pipeline used for this study.
2.2. Psychometric Data
Three scales were used to collect clinical information pre-
and post-treatment.
2.2.1. PSYRATS
Psychotic Symptom Rating Scales (PSYRATS) auditory
hallucinations subscale (AHS) is an interview measuring
auditory hallucinations using 11 items rated on a five-point
ordinal scale (0–4). The scale measures the severity of AVH for
the past week in 11 dimensions which are: frequency, duration,
location, loudness, beliefs about origin, negative content,
intensity of negative content, amount of distress, intensity of
distress, disruption of life, and control. PSYRATS has shown
excellent inter-rater reliability and good discriminant and
convergent validity for both chronic and first episode psychosis
(Haddock et al., 1999; Drake et al., 2007).
2.2.2. Quality of Life Scale (QoLS)
Quality of life was assessed with a 16 item self-report scale,
consisting of five conceptual domains of quality of life: material
and physical well-being, relationships with other people, social
community and civic activities, personal development and
fulfillment, and recreation. The scale has been shown to have
good test-retest reliability and good convergent and discriminant
validity (Flanagan, 1978).
2.2.3. Depression Anxiety Stress Scales (DASS)
The DASS is a measure of mental health focusing on the three
traits of depression, anxiety, and stress. It consists of 42 items,
rated on a four point Likert type scale of howmuch that symptom
occurred in the last week. In clinical samples the scale has shown
excellent internal consistency and temporal stability as well as
excellent discriminant validity and good convergent validity
(Brown et al., 1997).
2.3. P300 Recordings
P300 was measured with an auditory oddball paradigm attention
task. The recordings took place between 11h00 and 14h00 for
a duration of 1 h. The subjects sat with their eyes closed. The
frequent (F) and the rare (R) auditory stimuli were presented
binaurally through headphones at an interstimulus interval
between tones of constant 1.1 s. The loudness was adjusted for
each participant. For each subject, there was one trial of 200
tones, comporting a random tone occurrence with a probability
of 0.2, leading to 160 frequent tones and 40 rare (Marcu et al.,
2020). We required the participants to focus on the rare stimuli
without counting or moving a finger.
2.4. EEG Pre-processing and Analysis
The EEG was recorded using a 256 channel system (ANT
Neuro, Netherlands) with an electrooculogram (EOG) electrode
placed below the right eye and a ground electrode placed on
the left side of the neck. Data pre-processing and analysis were
performed with Brainstorm (Tadel et al., 2011) and MATLAB
2018b (MathWorks, Inc., Natick, 158 Massachusetts, USA).
2.4.1. Pre-processing
The data were sampled at 1,024 Hz and re-referenced to the
average of left and right mastoid electrodes (R19R, L19L). A
bandpass filter was set between 0.5 and 70 Hz and notch filter
from 49 to 51 Hz was used to remove undesired monomorphic
artifacts from 50 Hz mains electricity. Bad channels were
manually removed when EEG voltage was higher than ±80
µV; if more than 10% of the channels showed too much noise
or incorrect signal, the whole trial was rejected. The signals
were digitized in epochs of 1,200 ms, starting 500 ms before
the presentation of each auditory stimulus (–500 to +700 ms).
Baseline correction was performed using pre-stimulus 500 ms
to pre-stimulus 100 ms window and channels marked as bad
were removed and interpolated. Individual trials were visually
inspected and rejected when indicative of excessive muscle
activity, eye movements, or other artifacts.
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TABLE 1 | Socio-demographic information.
Group Id Gender Medication Diagnosis
TG T1 M Clozapine, Fluoxetine, Bupropion Paranoid Schizophrenia
TG T2 M Clozapine, Olanzapine, Perphenazine, Alprazolam, Levomepromazine, Oxazepam and Melatonin Paranoid Schizophrenia
TG T3 F Sertraline, Quetiapine, Pregabalin and Zopiclone Schizoaffective Disorder Depressive type
TG T4 M Clozapine and Flupenthixol Paranoid Schizophrenia
TG T5 M Clozapine, Amisulpiride, Propranolol and Clonazepam Paranoid Schizophrenia
CG C1 M Paliperidone, Quetiapine and Perphenazine Paranoid Schizophrenia
CG C2 F Clozapine, Flupenthixol, Zopiclone, Mirtazapine, Escitalopram, Metoprolol and Chlorpromazine Paranoid Schizophrenia
CG C3 F Aripiprazole, Olanzapine, Chlorprothixene and Pregabalin Paranoid Schizophrenia
CG C4 M Clozapine, Olanzapine, Bupropion and Propranolol Paranoid Schizophrenia
CG C5 M Clozapine, Pregabalin, Amisulpride Hebephrenic Schizophrenia
(Group : TG, T3-P3 group; CG, Cz group. Gender : M, man; F, woman.).
FIGURE 1 | Data acquisition and processing workflow.
2.4.2. Data Analysis
2.4.2.1. Time Domain
N100-P300 complex values of both frequent and rare stimuli were
calculated and plotted via MATLAB 2018b for each subject (pre-
and post-treatment for patients groups).
The scalp was divided into 5 regions of interest (ROI), see
Figure 2. The 254 electrodes were partitioned as follows: 80
channels for the Frontal region (F), 59 for the Parietal region (P),
69 for the Occipital region (O), 23 for Right Temporal lobe (RT),
and 23 for Left Temporal lobe (LT) (Schartner et al., 2015).
N1-P3 wave signals were calculated for the entire N100-P300
complex from the average of channels of every ROI as the
difference between the most negative voltage value within time
range of 80–150 ms (N100) and the most positive voltage value
within time range of 250–500 ms (P300).
The differences between frequent and rare stimulus and pre-
and post-treatment were also computed and plotted.
2.4.2.2. Frequency Domain
The power spectral density (PSD) was computed for each epoch
with Welch’s method, using Brainstorm, with the following
frequency bands: delta (0.5–4 Hz), theta (4–8 Hz), alpha (8–13
Hz), beta (13–30 Hz), gamma (30–70 Hz). The PSD has been
divided by the associated bandwidth for each frequency band.
Using the same scalp division as that of the time analysis,
the PSD of electrodes within the same ROI were averaged for
frequent and rare stimuli, pre- and post-treatment for each
subject.
The PSD difference post-pre treatment and frequent—rare
were computed for each subject.
2.4.2.3. Connectivity
The connectivity has been computed at the cortical level using
the "EEG source connectivity" method. It consists of estimating
the brain sources (over 68 regions of interest—ROI—) and then
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FIGURE 2 | Pre-processing and analysis workflow.
computing the statistical coupling between these reconstructed
sources. The weighted minimum norm estimate (wMNE) and
the Phase Locking Value (PLV) were used to solve the inverse
problem and compute the functional connectivity, respectively.
This choice was based on previous comparative studies showing
good performance of this combination on simulated and real
data. (Hassan et al., 2014, 2017; Hassan and Wendling, 2018).
The analysis has been performed only on the beta and gamma
bands, due to window length constraints (here 700 ms). The
source-space networks were estimated for each trial, subject and
conditions. To compare between conditions, the networks were
quantified using network measures that allow the extraction
of the topological properties of the networks. We made the
choice here to focus on network integration as it is the most
consistent network feature that changes due to electric/magnetic
stimulation (Modolo et al., 2020) or brain disorders (Stam,
2014). The network integration reflects the ability of the brain
network to integrate information form different and distant
brain regions, a key feature of efficient information processing.
To quantify the network integration, we used the participation
coefficient (PC), to calculate the interactions between brain
modules (distant sub-networks), on the thresholded connectivity
matrices (here 20%). We used the brain connectivity toolbox




The analysis for each individual revealed general consistent
results. The results picturing the evolution (increase or decrease)
of the neurophysiological and psychometric data and are detailed
in Table 2 for the TG, and in Table 3 for the CG. The associated
numerical values are detailed inTable 4 for the TG and inTable 5
for the CG. The analysis of the psychometric tests revealed that
four out of five subjects in TG (Tables 2, 4) and three out of
five subjects in CG (Tables 3, 5) felt improved condition after
the treatment, whereas the other subjects remained neutral or
reported worse psychometric scores. In the time domain analysis,
the N1-P3 amplitude was globally higher post-treatment than
pre-treatment, for six subjects, two in TG (Tables 2, 4) and four
in CG (Tables 3, 5). The PSD increased post-treatmentmainly for
the alpha band and beta band globally, for six subjects as well, two
in TG (Tables 2, 4) and four in CG (Tables 3, 5). No trends were
detectable for the gamma and theta bands. In several subjects, the
right temporal area showed an opposite behavior compared to
the other regions. The connectivity results showed an increased
network integration (increase in participation coefficient) during
post-treatment for frequent, for the beta band especially, for
seven subjects, four in CG (Tables 3, 5), three in TG (Tables 2, 4).
Due to the small sample size and high variability of the results,
we will discuss selected study cases individually. The following
four patients were selected due to their interplay between
psychometric score and neurophysiological results, independant
of treatment. Two subjects (T2, in TG and C3, in CG) presented
an improvement in the psychometric score post-TMS, and the
two others presented a stagnation in the psychometric (C2,
in CG) or a decrement (T5, in TG). The rest of the data
are provided in the Supplementary Material. There were no
significant changes on AVH severity measured with PSYRATS
AHS, in QoL and DASS global scores after rTMS between TG
and CG.
3.2. Study Case 1 : Improvement in
Psychometric Score
The two patients detailed in this section presented an
improvement in their psychometric score post-treatment. We
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TABLE 2 | Treated Group: Increase (↑), decrease (↓), or constancy (–) of the value after treatment of N1-P3, Connectivity, Psychometric and Power spectral density (PSD)
of the frequent (blue) and rare (orange) stimuli (F, frontal; P, parietal; O, occipital; LT, left temporal; RT, right temporal).
N1-P3 amplitude (µV) Connectivity Psychometrics
F P O LT RT Participation coefficient (%) QoL DASS PSYRATS
T1 ↑↑ -↓ ↑↓ ↓↓ ↑↓ ↑ ↑ - ↓
T2 ↓↓ -↑ ↓↓ ↓↑ ↓↓ ↑ ↑ ↓ ↓
T3 -↑ ↑↑ ↓↓ ↓- – - ↑ ↓ ↓
T4 ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ - - - ↓
T5 ↓↓ ↓- ↓↓ ↓↓ ↓↓ ↑ - ↑ ↑
Power spectral density
PSD: THETA PSD: ALPHA PSD: BETA PSD: GAMMA
F P O LT RT F P O LT RT F P O LT RT F P O LT RT
T1 -↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓- ↓↓ ↓↓ ↓↓ ↑- ↑↑ -↓ ↓↓ ↑↑
T2 ↓↓ ↓↓ ↓- ↓↓ ↓↑ ↑↑ -↑ ↑↑ ↑↑ ↑↑ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓
T3 ↓↓ ↓↓ ↓↓ ↓↓ ↓↑ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑
T4 ↓↓ ↓↓ -↓ ↑- ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑
T5 ↑↑ ↑↑ ↑↑ ↑↑ ↓- ↑↑ ↑↑ ↑↑ – ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↓↑ ↑↑ ↑↑ ↑↑ ↑↑ ↓↓
QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating Scales.
TABLE 3 | Control Group: Increase (↑), decrease (↓) or constancy (-) of the value after treatment of N1-P3, Connectivity, Psychometric and Power Spectral Density (PSD)
of the frequent (blue) and rare (orange) stimuli(F, frontal; P, parietal; O, occipital; LT, left temporal; RT, right temporal).
N1-P3 amplitude (µV) Connectivity Psychometrics
F P O LT RT Participation coefficient (%) QoL DASS PSYRATS
C1 ↓↑ ↓↑ ↓ ↑ ↓↑ ↓↑ - - ↓ -
C2 – ↓↓ -↑ ↑↑ ↑↑ ↑ - - -
C3 ↑↑ ↑↑ ↑↑ ↑↓ ↑↓ ↑ ↑ ↓ -
C4 ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↑ ↓ ↓ -
C5 ↓↓ ↓↓ ↓↑ ↓↑ ↓↑ ↑ ↓ ↑ -
Power spectral density
PSD: THETA PSD: ALPHA PSD: BETA PSD: GAMMA
F P O LT RT F P O LT RT F P O LT RT F P O LT RT
C1 -↑ ↓↓ ↓↓ ↓↓ ↓↑ ↓↓ ↓↓ ↓↓ ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ -↑ ↑↑ ↑↑ ↑↑ ↓- ↓↓ ↓↓
C2 ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↓↑ -↑ -↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ -↑ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓
C3 ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↓↓ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑ ↑↑
C4 ↓↓ ↓↓ ↓↓ ↓↑ ↓↓ ↓- – -↑ ↑↑ – ↓↓ ↓↓ ↓↓ ↑↑ -↓ ↓↓ ↓- ↓↓ ↓↑ ↓↓
C5 ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓
QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating Scales.
chose to describe them in this section due to their higher values
post treatment in the neurophysiological data, (Figures 3A,
4A) in order to find a potential correlation between those
two outcomes.
3.2.1. Patient T2
Patient T2 (Figure 3) is a man with paranoid schizophrenia,
in the TG, who took part in the study while taking : clozapine,
olanzapine, perphenazine, alprazolam, levomepromazine,
oxazepam, and melatonin. The psychometric tests (Figure 3A)
show an improvement of the quality of life post-treatment,
a decreased DASS after TMS and decreased PSYRATS post-
treatment. The temporal analysis (Figure 3D) showed a lower
N1-P3 amplitude post-treatment, except for the parietal and left
temporal parts. The PSD (Figure 3B) showed higher alpha power
post-TMS. However, the beta power is lower post-TMS. The
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TABLE 4 | Treatment Group: Values pre and post treatment of N1-P3, Connectivity, Psychometric and Power spectral density of the frequent (blue) and rare (orange)
stimuli(F, frontal; P, parietal; O, occipital; LT, left temporal; RT, right temporal).
Connectivity Psychometrics
Participation coefficient (%) QoL DASS PSYRATS
Pre Post Pre Post Pre Post Pre Post
T1 1 9 68 77 8 9 21 16
T2 6 13 55 75 92 85 32 25
T3 10 8 50 69 118 53 34 28
T4 9 10 94 91 5 4 30 23
T5 15 26 93 96 39 58 23 28
Freq P O LT RT
Pre Post Pre Post Pre Post Pre Post Pre Post
Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare F Rare F Rare F Rare
N1-P3 amplitude (uV)
T1 3.52 6.91 4.12 7.33 5.05 10.08 4.85 7.85 3.91 5.58 4.37 2.77 6.50 10.49 5.15 8.60 5.25 8.32 6.03 7.42
T2 2.05 6.77 1.61 4.27 1.72 4.73 1.56 5.33 2.10 5.25 1.33 4.43 4.64 9.75 1.02 10.06 3.66 9.33 0.99 8.30
T3 5.24 5.17 5.36 10.14 5.59 8.93 6.68 10.02 5.50 7.03 4.67 5.78 5.98 10.81 5.40 10.79 5.40 9.53 5.18 9.81
T4 3.39 6.60 8.11 12.37 3.31 6.72 7.81 12.22 3.50 5.53 7.23 13.33 5.12 5.96 7.49 14.11 4.11 5.24 7.07 12.93
T5 2.68 4.58 2.47 4.10 3.51 5.06 2.72 5.15 3.82 5.08 3.15 4.48 5.20 6.70 3.42 4.42 5.22 6.21 3.39 4.46
Power spectral density : Theta band (µV2/Hz)x10−15
T1 172 338 105 235 152 244 94 255 145 262 95 208 124 228 109 356 196 225 166 259
T2 59 120 21 170 44 95 15 164 45 145 17 194 66 232 26 208 82 111 22 457
T3 88 130 47 292 59 102 19 139 43 107 17 171 58 66 27 527 77 424 70 599
T4 37 85 348 468 36 78 169 264 39 91 355 639 30 53 427 621 66 102 267 481
T5 112 379 83 317 197 378 44 148 279 386 47 134 113 261 95 322 364 504 69 303
Power spectral density : Alpha band (µV2/Hz)x10−15) l
T1 116 395 28 92 100 245 26 90 167 366 30 92 262 548 42 175 221 697 53 100
T2 67 348 40 484 65 217 37 393 66 241 62 490 32 295 61 521 203 340 106 1047
T3 109 304 44 493 84 111 22 176 120 178 43 273 87 278 55 332 300 573 97 413
T4 31 52 39 244 14 21 31 137 35 59 56 170 17 44 45 118 38 109 44 255
T5 24 86 11 45 34 136 9 31 45 198 9 27 19 87 14 32 61 235 17 40
Power spectral density : Beta band (µV2/Hz)x10−15
T1 7 28 6 37 6 19 5 37 15 48 6 40 16 69 7 27 15 44 11 129
T2 21 93 13 50 22 93 13 50 28 127 18 65 33 258 14 50 50 177 31 84
T3 29 138 10 99 20 103 4 59 33 218 8 113 54 405 13 108 43 339 21 282
T4 3 13 31 111 2 10 31 110 4 14 33 110 3 14 40 118 4 16 22 121
T5 9 47 3 8 9 45 3 6 11 46 3 7 11 46 3 11 15 68 3 7
Power spectral density : Gamma band (µV2/Hz)x10−15
T1 0.8 6 3 8 0.5 4 3 7 2 11 3 8 2 14 2 5 0.9 7 5 17
T2 10 46 1 3 11 49 1 3 12 54 1 4 14 59 1 2 14 67 2 5
T3 0.6 3 4 47 0.5 2 2 20 0.8 3 3 33 0.5 3 4 37 0.6 2 6 57
T4 1 3 16 51 1 2 15 52 1 4 19 63 2 4 19 68 2 4 14 52
T5 3 12 1 3 3 15 1 3 3 17 1 4 3 13 2 7 4 19 1 4
QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating Scales.
connectivity (Figure 3C) revealed a clear higher participation
coefficient (represented by the larger green nodes), especially
in the left central, left orbito-frontal and the right occipital
brain regions. The frontal area showed a relatively lower
participation coefficient.
3.2.2. Patient C3
Patient C3 (Figure 4) is a woman with paranoid schizophrenia,
in the CG, who tool part in the study while taking :
aripriprazole, olanzapine, chloroprothixene, and pregabalin. The
psychometric outcome (Figure 4A) revealed an improvement
after the treatment. The quality of life increased, the DASS
decreased, while the PSYRATS did not change. The time
domain analysis (Figure 4D) showed a higher amplitude of the
N1-P3 complex after the treatment, except on the temporal
regions for the rare stimulus. The PSD (Figure 4B) showed
higher alpha power post-TMS, except from the right temporal
region for both frequent and rare stimuli. The beta band
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TABLE 5 | Control Group: Values pre and post treatment of N1-P3, Connectivity, Psychometric and Power spectral density of the frequent (blue) and rare (orange)
stimuli(F, frontal; P, parietal; O, occipital; LT, left temporal; RT, right temporal).
Connectivity Psychometrics
Participation coefficient (%) QoL DASS PSYRATS
Pre Post Pre Post Pre Post Pre Post
C1 29 26 83 84 34 26 28 28
C2 11 15 68 69 52 56 31 29
C3 8 16 41 79 80 42 32 31
C4 13 20 86 78 89 81 31 30
C5 1 22 96 82 11 18 30 27
Freq P O LT RT
Pre Post Pre Post Pre Post Pre Post Pre Post
Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare Freq Rare F Rare F Rare F Rare
N1-P3 amplitude (µV)
C1 2.94 4.38 2.16 8.27 4.22 4.87 2.71 6.80 2.71 3.09 1.31 7.94 4.61 7.05 0.91 9.58 3.77 6.11 1.49 9.53
C2 8.79 10.26 7.93 10.7 9.54 15.23 8.03 10.98 7.04 7.89 7.67 10.49 5.75 6.22 7.90 14.49 5.84 5.33 7.76 10.88
C3 1.02 3.01 5.16 7.43 2.08 4.59 6.84 8.67 2.01 5.51 5.65 8.42 5.31 11.63 6.89 9.31 5.09 10.61 7.01 9.61
C4 6.49 4.38 1.65 2.15 6.09 5.50 1.63 2.18 5.86 6.83 1.16 1.69 5.97 10.90 1.23 2.01 5.62 10.07 1.22 1.58
C5 5.10 4.71 4.16 2.57 9.16 14.05 4.40 5.72 5.31 5.08 2.62 8.73 8.31 11.93 4.01 13.87 9.00 10.37 4.03 12.49
Power spectral density : Theta band (µV2/Hz)x10−15
C1 46 154 68 381 42 146 62 192 45 141 51 195 78 129 59 167 46 118 76 382
C2 647 1651 544 792 245 606 299 289 153 506 188 264 571 1484 156 754 212 1933 311 459
C3 34 42 61 85 29 48 53 79 44 64 73 105 14 86 40 150 80 137 119 102
C4 653 1580 38 175 506 1430 37 190 688 2157 78 216 577 3253 231 328 793 2011 38 225
C5 660 763 429 1919 748 847 281 1543 945 1078 317 1453 1759 1273 1425 3293 1251 1098 200 2306
Power spectral density : Alpha band (µV2/Hz)x10−15
C1 34 120 51 215 44 85 35 129 40 116 43 181 46 259 69 174 26 97 45 112
C2 165 849 196 207 97 304 142 156 152 227 174 191 424 563 199 187 162 756 120 325
C3 39 105 79 141 27 94 73 106 34 135 90 153 17 50 130 185 48 345 62 219
C4 139 229 10 73 66 188 10 79 116 238 24 170 306 580 87 391 131 192 10 85
C5 54 177 78 220 57 153 61 218 63 204 77 247 59 340 66 353 55 282 100 347
Power spectral density : Beta band (µV2/Hz)x10−15
C1 6 16 9 61 5 17 8 47 5 23 11 58 6 40 18 102 6 24 13 70
C2 18 32 34 29 8 16 21 17 6 19 13 20 17 27 22 43 15 57 28 28
C3 5 11 11 22 5 13 10 22 4 12 12 33 5 10 17 47 5 16 11 23
C4 25 102 4 11 16 60 4 11 23 83 6 23 38 178 14 40 21 76 6 12
C5 8 18 15 58 7 14 12 54 7 14 15 66 7 15 36 190 8 21 10 56
Power spectral density : Gamma band (µV2/Hz)x10−15
C1 2 7 3 21 2 5 2 20 3 8 3 21 5 23 6 48 4 9 3 18
C2 8 20 0.5 0.4 6 16 0.3 0.3 6 18 0.2 0.3 9 24 0.4 0.5 8 27 0.3 0.3
C3 3 7 6 24 3 8 6 24 3 9 8 30 6 19 13 42 4 11 5 27
C4 3 19 0.2 2 3 14 0.2 2 4 28 0.2 2 7 41 0.5 8 7 27 0.3 2
C5 2 4 1 7 2 4 1 5 1 4 1 7 2 4 4 13 3 7 1 5
QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating Scales.
also showed a higher PSD post-TMS. Finally, the connectivity
study (Figure 4C) displayed a globally improved participation
coefficient, principally in the frontal, occipital, and central areas
of the brain.
3.3. Study Case 2 : Stagnation in
Psychometric Score
The patient detailed in this section presented a stagnation in
her psychometric score post treatment (Figure 5A). We chose to
describe her in this section in order to find a potential correlation
with the neurophysiological data.
3.3.1. Patient C2
Patient C2 (Figure 5) is a woman with paranoid schizophrenia,
in the CG, who took part in the study while taking : clozapine,
flupenthixol, zopiclone, mirtazapine, escitalopram, metoprolol,
and chlorpomazine. The psychometric data (Figure 5A) showed
that the treatment did not have a lot of impact on this scale.
The quality of life, the DASS and the PSYRATS remained
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FIGURE 3 | Results of patient T2 : (A) psychometric; (B) Scalp-level frequency analysis; (C) Source-space connectivity; (D) Scalp-level time analysis. The yellow areas
in frequency analysis are related to a higher Power Spectral Density (PSD) post-treatment, whereas the blue ones are related to a higher PSD pre-treatment. The size
of the node in the connectivity is related to the amount of increase (green) or decrease (orange) participation coefficient (PC) values. The positive bars in time analysis
are related to a higher N1-P3 amplitude post-treatment. (QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating
Scales).
more or less the same. The time domain (Figure 5D) showed
a global increase of N1-P3 amplitude post-TMS, except for the
parietal region for both stimuli and the frontal region for the
frequent stimulus. The PSD analysis (Figure 5B) showed higher
alpha and beta power post-TMS (with the exception of frontal
frequent stimulus responses in the alpha band). The connectivity
analysis (Figure 5C) revealed a balanced participation evolution.
Globally the left hemisphere (mainly the entorhinal and frontal)
showed a decreased participation coefficient, and the right
areas (mainly the frontal and occipital) showed an increased
participation coefficients.
3.4. Study Case 3 : Decrease in
Psychometric Score
The patient detailed in this section presented a decrease in their
psychometric score post treatment.We chose to describe him due
to his lower values in the neurophysiological data post treatment
(Figure 6A), in order to find a potential correlation between
those two outcomes.
3.4.1. Patient T5
Patient T5 (Figure 6) is a man with paranoid schizophrenia, in
the TG, who took part in the study while taking : clozapine,
flupenthixol, zopiclone, mirtazapine, escitalopram, metoprolol,
and chlorpomazine. The psychometric data (Figure 6A) showed
very little effect of treatment on this scale. The quality of life
remained the same, the DASS increased and the PSYRATS
slightly increased. The time domain (Figure 6D) showed a global
decrease of N1-P3 amplitude post-TMS, except for the parietal
region for the rare stimulus. The PSD analysis (Figure 6B)
showed a lower alpha power post-TMS, except for the right
temporal region. The beta power decreased as well, except
for the right temporal region for the frequent stimulus. The
connectivity analysis (Figure 6C) showed a globally higher
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FIGURE 4 | Results of patient C3 : (A) psychometric; (B) Scalp-level frequency analysis; (C) Source-space connectivity; (D) Scalp-level time analysis. The yellow
areas in frequency analysis are related to a higher Power Spectral Density (PSD) post-treatment, whereas the blue ones are related to a higher PSD pre-treatment. The
size of the node in the connectivity is related to the amount of increase (green) or decrease (orange) participation coefficient (PC) values. The positive bars in time
analysis are related to a higher N1-P3 amplitude post-treatment. (QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom
Rating Scales).
participation coefficient in the right frontal, left central, and
occipital brain regions.
4. DISCUSSION
The present work aimed to develop hypothesis to assess the
effects of TMS in schizophrenia with AVH, analysing EEG
data and psychometric outcome. This was based on three
different approaches : temporal size (with the calculation of N1P3
complex amplitude), spectral [with the evaluation of the PSD in
several frequency bands (theta, alpha, beta, and gamma)] and
connectivity, (with the calculation of the participation coefficient
in beta and gamma band).
The general results from our study revealed a high variability
between individuals, in both groups. This can be explained in
several ways : Firstly, subjects were taking a range of medications
all of which can interfere with the background neural activity and
the generation of ERPs (Javitt et al., 2008). Secondly, the long
and tiring recording procedure (around 1 h), and the different
states of the patients during the protocol could also have led to
varying data quality. Indeed, Polich (1997) highlights the fact
that background EEG variation contributes significantly to a high
P300 individual variability.
However, there were some indications of improvement in
the psychometric results, in four out of five subjects in TG and
three out of five in CG. Half of our subjects (six out of 10, four
CG, two TG) showed an increase of the N1-P3 amplitude after
the treatment, especially for the rare stimulus. Bramon et al.
(2004) and Jeon and Polich (2003) established that patients with
schizophrenia and AVH presented an inhibition to the P300
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FIGURE 5 | Results of patient C2 : (A) psychometric; (B) Scalp-level frequency analysis; (C) Source-space connectivity; (D) Scalp-level time analysis. The yellow
areas in frequency analysis are related to a higher Power Spectral Density (PSD) post-treatment, whereas the blue ones are related to a higher PSD pre-treatment. The
size of the node in the connectivity is related to the amount of increase (green) or decrease (orange) participation coefficient (PC) values. The positive bars in time
analysis are related to a higher N1-P3 amplitude post-treatment. (QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom
Rating Scales).
experiment. Thus, the clearer presence of N100 and P300 waves
post-TMS, which is a known response to the auditory oddball
task (Patel and Azzam, 2005), suggested a response to TMS.
Likewise, the spectral analysis displayed an increase of the PSD
in alpha and beta bands for six subjects (4 in CG, 2 in TG). Ray
and Cole (1985) demonstrated that those bands were directly
linked to attention, focus, emotional and cognitive processes. A
higher power in these bands could be indicative of a change in
those mechanisms. Finally, our brain connectivity results showed
a global increased participation coefficient in the beta band after
treatment, for six subjects (3 in TG, 4 in CG). These results lead us
to the conclusion that TMS seemed to have a positive impact on
the patients, in both groups. However, it is not possible to assume
that the location where the treatment was applied had a different
impact on the brain function. The results in connectivity analysis
show indeed an improved participation coefficient thus a better
network integration independently from the group. Therefore,
we discussed the results without regard to the patients’ group.
We chose to underline in the results section some patients that
showed an agreement between the psychometric scores and our
neurophysiological data.
It is interesting to note that for patient C3, where
the psychometric results were better post-TMS, all three
neurophysiological components used for this study revealed
a higher value post-TMS. For this patient, there seems to
be a clear link between clinical and neurophysiological
outcomes. For T2, the trend is there, but is less obvious, with
half of the neurophysiological results being in concordance
with the improved psychometric score. Conversely,
patient T5 had a deterioration in their psychometric
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FIGURE 6 | Results of patient T5 : (A) psychometric; (B) Scalp-level frequency analysis; (C) Source-space connectivity; (D) Scalp-level time analysis. The yellow areas
in frequency analysis are related to a higher Power Spectral Density (PSD) post-treatment, whereas the blue ones are related to a higher PSD pre-treatment. The size
of the node in the connectivity is related to the amount of increase (green) or decrease (orange) participation coefficient (PC) values. The positive bars in time analysis
are related to a higher N1-P3 amplitude post-treatment. (QoLS, Quality of Life Scale; DASS, Depression Anxiety Stress Scale; PSYRATS, Psychotic Symptom Rating
Scales).
post-TMS, and the same tendency is visible in their
neurophysiological data,
Although there was significant dissociation between clinical
and neurophysiological outcome, the participation coefficient
from the connectivity analysis was the parameter that seemed
to interact most closely with the psychometric results, followed
by alpha power. Concerning the connectivity analysis, our results
showed an increased network integration in some brain regions
and a slight decrease in other regions, different for every patient.
This reconfiguration of the brain network has been widely
reported in the literature when stimulating the brain using
electrical and magnetic means, and is also present in several
brain disorders (Fornito et al., 2015). The increased network
integration may be related to better information processing in
the human brain and more efficient networks. This increase in
network integration was associated with a decrease in this same
integration in other brain regions, reflecting the inter-subject
variability. Although the small sample size did not allow us to test
statistical significance, we showed a clear “trend” of reshaping of
the functional brain network between the different conditions.
The frequency analysis revealed the most interesting changes in
power spectrum, mainly in the alpha and beta bands. There was
higher alpha power post-TMS, which is less prominent but still
visible in the beta power. The gamma and theta power did not
show any clear trends. The fact that alpha and beta bands are
directly linked to attention, focus and emotional tasks (Ray and
Cole, 1985) is interesting. A higher power post-TMS linked with
a better score in the psychometric scale could indicate that the
improvement of these cognitive mechanisms was directly linked
to the progress of the patient’s clinical condition. Due to our
small sample size, this has to be put in perspective, and nothing
definitive can be assessed. However, there was a "trend" of an
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increase in alpha and beta powers post-TMS that is linked with
an improvement in the clinical outcome. Finally, the time domain
was the area of analysis presenting themost variability. Half of the
patients presented a higher N1-P3, especially in the rare stimuli,
but no clear trend was established between this outcome and the
clinical outcome. However, due to its conclusive results in studies
related to schizophrenia with AVH (Ogura et al., 1991; Ford et al.,
2001; Earls et al., 2016), our small number of subjects, as well as
its subject inter-variability (Polich, 1997), it is a paradigm that
should be taken in account in further studies.
Considering the fact that psychometric tests are a semi-self
assessment evaluation of patients condition, this work is a
first step toward a development of a hypothesis to correlate
and validate psychometrics with quantitative neurophysiological
data. We suggest further investigation of any link between
psychometrics and neurophysiological data under the umbrella
of TMS, focusing mainly on the participation coefficient in the
beta band and the power spectral density in alpha band. The beta
power as well as the N1-P3 amplitude should also be considered
of interest.
4.1. Limitations
The study has many limitations. Firstly, due to the very small
sample size, it was not possible to assess our results definitively.
Rather, we aimed to discover trends in order to generate
hypotheses for further study. Secondly, the patients were also
undergoing their usual treatment, including antipsychotic and
sedative medications. This did not change between pre- and
post-rTMS conditions but might have influenced the background
neural activity and the generation of the ERPs (Javitt et al., 2008).
Thirdly, the experimental procedure was long (1 h) and tiring
and some patients had difficulty cooperating and maintaining
task engagement, which may have affected data quality. Muscle
and movement artifacts added noise to the EEG signal, requiring
a thorough pre-processing and the exclusion of many trials.
We encourage similar experiments with patients in the supine
position to reduce the noise and improve the data quality, making
them easier to process and analyze. Finally, in this study we
only analyzed the oddball auditory paradigm. We recommend
pursuing this work using other procedures as well, in order to
have a more complete overview of the results.
4.2. Future Directives
Future studies of rTMS and neurophysiological markers in
schizophrenia should recruit larger number of participants than
the present study. The possible association of AVH and other
symptoms of schizophrenia with variations in P300, PSD and
other EEG markers should be studied further. This may help to
establish whether the PSD in the alpha and beta bands, the N1-
P3 complex and the participation coefficient in beta bands are
reliable biomarkers of the neural response to TMS in patients
with schizophrenia and AVH.
5. CONCLUSION
After conducting TMS, most patients showed an evolution
in psychometric data as well as on the neurophysiological
quantitative data, independent of the stimulation site. We
examined the interplay between the psychometric and the
neurophysiological data. When the psychometric improved post-
TMS, we could observe an increased network integration mainly,
through the participation coefficient in the beta bands, a higher
alpha and beta band power, and sometimes a higher N1-P3
amplitude. Due to the small sample size, it is not possible to
assess definitively the impact of TMS on the brain function in
schizophrenia, nor the correlation between psychometric and
neurophysiological data. However, our results suggest that brain
connectivity, through the participation coefficient, alpha and beta
power bands, were highly related with the psychometric score,
and that N1-P3, despite his variability, should be investigated.
This hypothesis will have to be verified in further studies, with
a larger sample size, and an improved recording procedure,
leading to a better data quality. This is a first step toward the
definition of quantitative neurophysiological parameters to assess
TMS treatment.
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